Open-mkt buys · 90d
$43.3K
3 trades · 1 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$43.3K
Insiders on file
18
Daily buy vs sell · 90 days
■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Dash Barry H | Director | 16 | $43.3K | $0 | 2026-10-09 |
| Plassche Douglas | Senior VP of Operations | 17 | $0 | $1.19M | 2026-01-09 |
| ELITE PHARMACEUTICALS INC /NV/ | EVP Operations | 3 | $0 | $260.0K | 2025-08-25 |
| Kirkov Kirko | Chief Commercial Officer | 2 | $9.7K | $0 | 2025-07-10 |
| Hakim Nasrat A | President & CEO | 24 | $217.0K | $0 | 2024-03-29 |
| Caskey Davis S | Director | 6 | $0 | $0 | 2023-11-22 |
| WHITNELL JEFFREY A | Director | 11 | $0 | $0 | 2023-11-22 |
| Chen Robert C J | CFO, Secretary, Treasurer | 1 | $0 | $0 | 2022-05-16 |
| Bregman Marc | CFO, Secretary, Treasurer | 1 | $0 | $0 | 2021-05-17 |
| Pfeifer Eugene M | Director | 2 | $0 | $0 | 2018-02-26 |
| Ward Carter Julian | Director | 15 | $0 | $34.1K | 2018-02-26 |
| NARINE JEENARINE | Other | 95 | $625.0K | $3.14M | 2016-04-13 |
| TREPPEL JERRY | Other | 32 | $0 | $607.1K | 2016-03-18 |
| NIGALAYE ASHOK G | Scief Scientific Officer | 104 | $437.5K | $2.79M | 2015-09-14 |
| EPIC PHARMA LLC | 10% Owner | 76 | $437.5K | $3.16M | 2015-04-27 |
| EPIC INVESTMENTS, LLC | 10% Owner | 68 | $437.5K | $2.64M | 2015-04-23 |
| POTTI RAM | Director, 10% Owner | 51 | $437.5K | $635.4K | 2013-05-09 |
| DICK CHRIS | President & COO | 4 | $0 | $0 | 2013-03-07 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Dash Barry H | Director | P Buy | 2026-10-09 | 2026-10-19 | 100,000 | $0.26 | $26.0K | 3,365,555 | SEC↗ |
| Dash Barry H | Director | P Buy | 2026-08-19 | 2026-09-10 | 30,000 | $0.29 | $8.7K | 3,265,555 | SEC↗ |
| Dash Barry H | Director | P Buy | 2026-08-19 | 2026-09-10 | 30,000 | $0.29 | $8.6K | 3,265,555 | SEC↗ |
| Plassche Douglas | EVP Operations | M Exercise deriv | 2026-01-09 | 2026-01-13 | 2,500,000 | — | $0 | 0 | SEC↗ |
| Plassche Douglas | EVP Operations | M Exercise | 2026-01-09 | 2026-01-13 | 2,500,000 | $0.03 | $75.0K | 6,000,000 | SEC↗ |
| Plassche Douglas | EVP Operations | S Sale | 2025-10-02 | 2025-10-03 | 800,000 | $0.62 | $496.0K | 3,500,000 | SEC↗ |
| ELITE PHARMACEUTICALS INC /NV/ | EVP Operations | M Exercise deriv | 2025-08-25 | 2025-08-26 | 2,500,000 | — | $0 | 2,500,000 | SEC↗ |
| ELITE PHARMACEUTICALS INC /NV/ | EVP Operations | M Exercise | 2025-08-25 | 2025-08-26 | 2,500,000 | $0.03 | $75.0K | 4,300,000 | SEC↗ |
| ELITE PHARMACEUTICALS INC /NV/ | EVP Operations | S Sale | 2025-08-22 | 2025-08-26 | 500,000 | $0.52 | $260.0K | 1,800,000 | SEC↗ |
| Kirkov Kirko | Chief Commercial Officer | P Buy | 2025-07-10 | 2025-07-25 | 16,366 | $0.59 | $9.7K | 16,366 | SEC↗ |
| Plassche Douglas | EVP Operations | S Sale | 2025-07-08 | 2025-07-10 | 200,000 | $0.58 | $116.0K | 2,300,000 | SEC↗ |
| Plassche Douglas | EVP Operations | M Exercise deriv | 2025-07-03 | 2025-07-08 | 2,500,000 | — | $0 | 5,000,000 | SEC↗ |
| Plassche Douglas | EVP Operations | M Exercise | 2025-07-03 | 2025-07-08 | 2,500,000 | $0.03 | $75.0K | 2,500,000 | SEC↗ |
| Plassche Douglas | SVP of Operations | S Sale | 2024-10-24 | 2024-10-28 | 333,932 | $0.51 | $170.3K | 0 | SEC↗ |
| Plassche Douglas | SVP of Operations | S Sale | 2024-10-23 | 2024-10-28 | 800,000 | $0.49 | $392.0K | 333,932 | SEC↗ |
| Hakim Nasrat A | CEO, President | A Award | 2024-03-29 | 2024-04-02 | 49,534,368 | — | $0 | 216,649,250 | SEC↗ |
| Hakim Nasrat A | CEO, President | A Award | 2023-12-29 | 2023-12-29 | 2,223,147 | $0.07 | $155.6K | 2,223,147 | SEC↗ |
| Dash Barry H | Director | A Award | 2023-11-22 | 2023-11-27 | 547,657 | $0.04 | $21.9K | 3,235,555 | SEC↗ |
| Caskey Davis S | Director | A Award | 2023-11-22 | 2023-11-27 | 547,657 | $0.04 | $21.9K | 2,049,436 | SEC↗ |
| WHITNELL JEFFREY A | Director | A Award | 2023-11-22 | 2023-11-27 | 547,657 | $0.04 | $21.9K | 3,187,020 | SEC↗ |
| Plassche Douglas | Executive VP Operations | A Award deriv | 2023-01-03 | 2023-06-26 | 7,500,000 | $0.03 | $225.0K | 7,500,000 | SEC↗ |
| Kirkov Kirko | Chief Commercial Officer | A Award deriv | 2022-09-06 | 2022-11-14 | 3,000,000 | $0.04 | $120.0K | 3,000,000 | SEC↗ |
| Dash Barry H | Director | A Award | 2022-08-28 | 2022-08-29 | 459,536 | $0.04 | $18.4K | 2,687,898 | SEC↗ |
| Caskey Davis S | Director | A Award | 2022-08-28 | 2022-08-29 | 459,536 | $0.04 | $18.4K | 1,501,779 | SEC↗ |
| WHITNELL JEFFREY A | Director | A Award | 2022-08-28 | 2022-08-29 | 459,536 | $0.04 | $18.4K | 2,639,363 | SEC↗ |
| Chen Robert C J | CFO, Secretary, Treasurer | A Award deriv | 2022-05-16 | 2022-07-07 | 900,000 | $0.04 | $36.0K | 900,000 | SEC↗ |
| Dash Barry H | Director | A Award | 2021-06-30 | 2021-07-01 | 295,570 | $0.07 | $20.7K | 2,228,182 | SEC↗ |
| Caskey Davis S | Director | A Award | 2021-06-30 | 2021-07-01 | 295,570 | $0.07 | $20.7K | 1,042,243 | SEC↗ |
| WHITNELL JEFFREY A | Director | A Award | 2021-06-30 | 2021-07-01 | 295,570 | $0.07 | $20.7K | 2,179,827 | SEC↗ |
| Bregman Marc | CFO, Secretary, Treasurer | A Award deriv | 2021-05-17 | 2021-07-07 | 300,000 | $0.06 | $18.0K | 300,000 | SEC↗ |
| Hakim Nasrat A | CEO & President | C Conversion deriv | 2020-08-24 | 2020-08-26 | 24 | — | $0 | 0 | SEC↗ |
| Hakim Nasrat A | CEO & President | C Conversion | 2020-08-24 | 2020-08-26 | 158,017,321 | — | $0 | 167,114,882 | SEC↗ |
| Dash Barry H | Director | A Award | 2020-08-20 | 2020-08-24 | 516,781 | $0.09 | $46.5K | 1,932,612 | SEC↗ |
| WHITNELL JEFFREY A | Director | A Award | 2020-08-20 | 2020-08-24 | 516,781 | $0.09 | $46.5K | 1,884,257 | SEC↗ |
| Caskey Davis S | Director | A Award | 2020-08-20 | 2020-08-24 | 516,781 | $0.09 | $46.5K | 746,673 | SEC↗ |
| Plassche Douglas | SVP Operations | A Award | 2020-08-20 | 2020-08-24 | 71,739 | $0.09 | $6.5K | 1,133,932 | SEC↗ |
| Plassche Douglas | SVP of Operations | A Award | 2020-06-30 | 2020-07-06 | 574,597 | $0.09 | $51.7K | 1,062,193 | SEC↗ |
| Caskey Davis S | Director | A Award | 2018-02-26 | 2018-02-27 | 161,374 | $0.12 | $19.4K | 229,892 | SEC↗ |
| Dash Barry H | Director | A Award | 2018-02-26 | 2018-02-27 | 161,374 | $0.12 | $19.4K | 1,415,831 | SEC↗ |
| WHITNELL JEFFREY A | Director | A Award | 2018-02-26 | 2018-02-27 | 161,374 | $0.12 | $19.4K | 1,367,476 | SEC↗ |
| Ward Carter Julian | CFO, Sec., Treas. | A Award | 2018-02-26 | 2018-02-27 | 242,060 | $0.12 | $29.0K | 2,127,364 | SEC↗ |
| Plassche Douglas | SVP of Operations | A Award | 2018-02-26 | 2018-02-27 | 201,717 | $0.12 | $24.2K | 487,596 | SEC↗ |
| Pfeifer Eugene M | Director | A Award | 2018-02-26 | 2018-02-27 | 161,374 | $0.12 | $19.4K | 233,414 | SEC↗ |
| Hakim Nasrat A | CEO & President | J Other deriv | 2017-04-28 | 2017-05-03 | 24 | $1000000.00 | $24.03M | 24 | SEC↗ |
| Hakim Nasrat A | CEO & President | J Other deriv | 2017-04-28 | 2017-05-03 | 79,008,661 | — | $0 | 79,008,661 | SEC↗ |
| Hakim Nasrat A | CEO & President | J Other | 2017-04-28 | 2017-05-03 | 158,017,321 | — | $0 | 9,097,561 | SEC↗ |
| Hakim Nasrat A | CEO & President | A Award | 2017-02-23 | 2017-02-27 | 2,216,992 | $0.23 | $509.9K | 24,143,785 | SEC↗ |
| Dash Barry H | Director | A Award | 2017-02-23 | 2017-02-27 | 88,679 | $0.23 | $20.4K | 1,254,457 | SEC↗ |
| WHITNELL JEFFREY A | Director | A Award | 2017-02-23 | 2017-02-27 | 88,679 | $0.23 | $20.4K | 1,206,102 | SEC↗ |
| Ward Carter Julian | Director | A Award | 2017-02-23 | 2017-02-27 | 133,019 | $0.23 | $30.6K | 1,885,304 | SEC↗ |
| Plassche Douglas | SVP of Operations | A Award | 2017-02-23 | 2017-02-27 | 110,849 | $0.23 | $25.5K | 285,879 | SEC↗ |
| Caskey Davis S | Director | A Award | 2017-02-23 | 2017-02-27 | 68,518 | $0.20 | $13.7K | 68,518 | SEC↗ |
| Pfeifer Eugene M | Director | A Award | 2017-02-23 | 2017-02-27 | 72,040 | $0.20 | $14.4K | 72,040 | SEC↗ |
| Hakim Nasrat A | CEO & President | M Exercise deriv | 2016-08-17 | 2016-08-19 | 100 | — | $0 | 0 | SEC↗ |
| Hakim Nasrat A | CEO & President | M Exercise | 2016-08-17 | 2016-08-19 | 142,857,143 | — | $0 | 142,971,097 | SEC↗ |
| Ward Carter Julian | CFO, Secretary, Treasurer | C Conversion deriv | 2016-04-28 | 2016-05-03 | 666,667 | — | $0 | 0 | SEC↗ |
| Ward Carter Julian | CFO, Secretary, Treasurer | C Conversion | 2016-04-28 | 2016-05-03 | 666,667 | $0.06 | $40.0K | 1,752,285 | SEC↗ |
| NARINE JEENARINE | Other | C Conversion deriv | 2016-04-13 | 2016-04-15 | 1,242,334 | — | $0 | 2,935,986 | SEC↗ |
| NARINE JEENARINE | Other | C Conversion deriv | 2016-04-13 | 2016-04-15 | 333,333 | — | $0 | 0 | SEC↗ |
| NARINE JEENARINE | Other | C Conversion deriv | 2016-04-13 | 2016-04-15 | 2,424,333 | — | $0 | 0 | SEC↗ |
| NARINE JEENARINE | Other | C Conversion | 2016-04-13 | 2016-04-15 | 4,000,000 | $0.06 | $240.0K | 16,742,395 | SEC↗ |
| TREPPEL JERRY | Other | S Sale | 2016-03-18 | 2016-03-21 | 258,090 | $0.34 | $87.8K | 7,640,561 | SEC↗ |
| TREPPEL JERRY | Other | S Sale | 2016-03-17 | 2016-03-21 | 312,430 | $0.35 | $109.4K | 7,898,651 | SEC↗ |
| TREPPEL JERRY | Other | S Sale | 2016-02-24 | 2016-02-24 | 100,456 | $0.31 | $31.1K | 8,211,081 | SEC↗ |
| TREPPEL JERRY | Other | S Sale | 2016-02-22 | 2016-02-24 | 100,000 | $0.32 | $32.0K | 8,311,537 | SEC↗ |
| TREPPEL JERRY | Other | S Sale | 2016-02-17 | 2016-02-18 | 50,000 | $0.31 | $15.5K | 8,411,537 | SEC↗ |
| Dash Barry H | Director | A Award | 2016-02-16 | 2016-02-18 | 81,549 | $0.25 | $20.4K | 1,165,778 | SEC↗ |
| NARINE JEENARINE | Director | A Award | 2016-02-16 | 2016-02-18 | 81,549 | $0.25 | $20.4K | 12,742,395 | SEC↗ |
| WHITNELL JEFFREY A | Director | A Award | 2016-02-16 | 2016-02-18 | 81,549 | $0.25 | $20.4K | 1,117,423 | SEC↗ |
| Hakim Nasrat A | Chairman, CEO, President | A Award | 2016-02-16 | 2016-02-18 | 2,854,279 | $0.25 | $713.6K | 22,040,747 | SEC↗ |
| Plassche Douglas | Exec Vice Pres Operations | A Award | 2016-02-16 | 2016-02-18 | 47,767 | $0.26 | $12.4K | 175,030 | SEC↗ |
| TREPPEL JERRY | Other | A Award | 2016-02-16 | 2016-02-18 | 124,646 | $0.25 | $31.2K | 8,461,537 | SEC↗ |
| TREPPEL JERRY | Other | S Sale | 2016-02-05 | 2016-02-18 | 24,400 | $0.33 | $8.1K | 8,336,891 | SEC↗ |
| TREPPEL JERRY | Other | S Sale | 2016-02-04 | 2016-02-18 | 349,660 | $0.32 | $111.9K | 8,361,291 | SEC↗ |
| TREPPEL JERRY | Other | S Sale | 2016-02-03 | 2016-02-18 | 45,518 | $0.33 | $15.0K | 8,710,951 | SEC↗ |
| TREPPEL JERRY | Other | S Sale | 2016-02-02 | 2016-02-18 | 13,000 | $0.33 | $4.3K | 8,756,469 | SEC↗ |
| TREPPEL JERRY | Other | S Sale | 2016-02-01 | 2016-02-18 | 312,300 | $0.34 | $106.2K | 8,769,469 | SEC↗ |
| TREPPEL JERRY | Other | S Sale | 2016-01-29 | 2016-02-18 | 115,000 | $0.35 | $40.3K | 9,081,769 | SEC↗ |
| NARINE JEENARINE | Director | G Gift deriv | 2015-12-31 | 2016-01-08 | 6,000,000 | — | $0 | 3,910,532 | SEC↗ |
| NARINE JEENARINE | Director | G Gift | 2015-12-31 | 2016-01-08 | 6,000,000 | — | $0 | 12,262,006 | SEC↗ |
| TREPPEL JERRY | Chairman of Board | S Sale | 2015-11-18 | 2015-11-18 | 25,000 | $0.31 | $7.8K | 9,196,769 | SEC↗ |
| TREPPEL JERRY | Chairman of Board | S Sale | 2015-11-17 | 2015-11-18 | 25,000 | $0.30 | $7.5K | 9,221,769 | SEC↗ |
| TREPPEL JERRY | Chairman of Board | S Sale | 2015-11-16 | 2015-11-18 | 50,000 | $0.30 | $15.0K | 9,246,769 | SEC↗ |
| TREPPEL JERRY | Chairman of Board | S Sale | 2015-11-13 | 2015-11-18 | 50,000 | $0.30 | $15.0K | 9,296,769 | SEC↗ |
| TREPPEL JERRY | Chairman of Board | G Gift | 2015-11-13 | 2015-11-18 | 7,500 | $0.31 | $2.3K | 9,346,769 | SEC↗ |
| NARINE JEENARINE | Director | J Other | 2015-10-30 | 2016-01-08 | 398,840 | — | $0 | 398,840 | SEC↗ |
| Hakim Nasrat A | President & CEO | J Other | 2015-10-30 | 2016-01-08 | 113,954 | — | $0 | 113,954 | SEC↗ |
| NIGALAYE ASHOK G | Director | G Gift deriv | 2015-09-14 | 2015-10-20 | 5,697,710 | — | $0 | 0 | SEC↗ |
| NIGALAYE ASHOK G | Director | G Gift deriv | 2015-09-14 | 2015-10-20 | 454,665 | — | $0 | 0 | SEC↗ |
| NIGALAYE ASHOK G | Director | G Gift deriv | 2015-09-14 | 2015-10-20 | 2,684,137 | — | $0 | 0 | SEC↗ |
| NIGALAYE ASHOK G | Director | G Gift deriv | 2015-09-14 | 2015-10-20 | 1,324,333 | — | $0 | 0 | SEC↗ |
| Plassche Douglas | 10% Owner | A Award | 2015-08-14 | 2015-08-18 | 54,169 | $0.23 | $12.5K | 127,263 | SEC↗ |
| Hakim Nasrat A | President & CEO | C Conversion deriv | 2015-06-02 | 2015-06-04 | 759,695 | — | $0 | 0 | SEC↗ |
| Hakim Nasrat A | President & CEO | C Conversion deriv | 2015-06-02 | 2015-06-04 | 1,982,106 | — | $0 | 0 | SEC↗ |
| Hakim Nasrat A | President & CEO | C Conversion | 2015-06-02 | 2015-06-04 | 2,741,801 | $0.06 | $164.5K | 5,311,819 | SEC↗ |
| NIGALAYE ASHOK G | Director | C Conversion deriv | 2015-05-21 | 2015-05-21 | 2,000,000 | $0.06 | $120.0K | 2,000,000 | SEC↗ |
| NIGALAYE ASHOK G | Director | C Conversion | 2015-05-21 | 2015-05-21 | 2,000,000 | $0.06 | $120.0K | 40,442,232 | SEC↗ |
| NIGALAYE ASHOK G | Director, 10% Owner | C Conversion deriv | 2015-05-05 | 2015-05-13 | 2,000,000 | — | $0 | 454,665 | SEC↗ |
| NIGALAYE ASHOK G | Director, 10% Owner | C Conversion | 2015-05-05 | 2015-05-13 | 2,000,000 | $0.06 | $120.0K | 38,442,232 | SEC↗ |
| NIGALAYE ASHOK G | Director, 10% Owner | G Gift deriv | 2015-05-04 | 2015-05-13 | 350,000 | — | $0 | 1,324,333 | SEC↗ |
| EPIC PHARMA LLC | 10% Owner | J Other | 2015-04-27 | 2015-04-27 | 67,659,232 | — | $0 | 0 | SEC↗ |
| Plassche Douglas | Executive VP of Operations | S Sale | 2015-04-27 | 2015-04-28 | 85,530 | $0.24 | $20.5K | 73,094 | SEC↗ |
| EPIC INVESTMENTS, LLC | 10% Owner | J Other | 2015-04-23 | 2015-04-27 | 67,659,232 | — | $0 | 0 | SEC↗ |
| NIGALAYE ASHOK G | Director | J Other | 2015-04-23 | 2015-04-27 | 67,659,232 | — | $0 | 0 | SEC↗ |
| NIGALAYE ASHOK G | Director | J Other | 2015-04-23 | 2015-04-27 | 19,275,133 | — | $0 | 55,717,363 | SEC↗ |
| NARINE JEENARINE | Director | J Other | 2015-04-23 | 2015-04-27 | 67,659,232 | — | $0 | 0 | SEC↗ |
| NARINE JEENARINE | Director | J Other | 2015-04-23 | 2015-04-27 | 12,850,089 | — | $0 | 31,269,108 | SEC↗ |
| Hakim Nasrat A | President & CEO | J Other | 2015-04-23 | 2015-04-27 | 2,570,018 | — | $0 | 2,570,018 | SEC↗ |
| NIGALAYE ASHOK G | Director, 10% Owner | J Other | 2015-04-23 | 2015-05-13 | 19,275,135 | — | $0 | 38,442,230 | SEC↗ |
| NIGALAYE ASHOK G | Director | J Other | 2015-04-23 | 2015-05-21 | 19,275,135 | — | $0 | 36,442,232 | SEC↗ |
| NIGALAYE ASHOK G | Director, 10% Owner | G Gift deriv | 2015-04-16 | 2015-04-16 | 1,250,000 | — | $0 | 1,204,665 | SEC↗ |
| NIGALAYE ASHOK G | Director, 10% Owner | G Gift deriv | 2015-04-16 | 2015-05-13 | 1,250,000 | — | $0 | 1,674,333 | SEC↗ |
| EPIC INVESTMENTS, LLC | 10% Owner | J Other deriv | 2015-04-03 | 2015-04-07 | 2,454,665 | — | $0 | 0 | SEC↗ |
| EPIC INVESTMENTS, LLC | 10% Owner | J Other deriv | 2015-04-03 | 2015-04-07 | 6,726,999 | — | $0 | 0 | SEC↗ |
| EPIC INVESTMENTS, LLC | 10% Owner | J Other deriv | 2015-04-03 | 2015-04-07 | 4,000,000 | — | $0 | 0 | SEC↗ |
| EPIC INVESTMENTS, LLC | 10% Owner | J Other deriv | 2015-04-03 | 2015-04-07 | 40,000,000 | — | $0 | 0 | SEC↗ |
| EPIC PHARMA LLC | 10% Owner | J Other deriv | 2015-04-03 | 2015-04-07 | 6,726,999 | — | $0 | 0 | SEC↗ |
| EPIC PHARMA LLC | 10% Owner | J Other deriv | 2015-04-03 | 2015-04-07 | 4,000,000 | — | $0 | 0 | SEC↗ |
| EPIC PHARMA LLC | 10% Owner | J Other deriv | 2015-04-03 | 2015-04-07 | 40,000,000 | — | $0 | 0 | SEC↗ |
| EPIC PHARMA LLC | 10% Owner | J Other deriv | 2015-04-03 | 2015-04-07 | 2,454,665 | — | $0 | 0 | SEC↗ |
| NARINE JEENARINE | Director, 10% Owner | J Other deriv | 2015-04-03 | 2015-04-07 | 6,726,999 | — | $0 | 0 | SEC↗ |
| NARINE JEENARINE | Director, 10% Owner | J Other deriv | 2015-04-03 | 2015-04-07 | 2,454,665 | — | $0 | 0 | SEC↗ |
| NARINE JEENARINE | Director, 10% Owner | J Other deriv | 2015-04-03 | 2015-04-07 | 40,000,000 | — | $0 | 0 | SEC↗ |
| NARINE JEENARINE | Director, 10% Owner | J Other deriv | 2015-04-03 | 2015-04-07 | 4,000,000 | — | $0 | 0 | SEC↗ |
| NARINE JEENARINE | Director, 10% Owner | J Other deriv | 2015-04-03 | 2015-04-07 | 9,910,532 | — | $0 | 9,910,532 | SEC↗ |
| NIGALAYE ASHOK G | Director, 10% Owner | J Other deriv | 2015-04-03 | 2015-04-07 | 40,000,000 | — | $0 | 0 | SEC↗ |
| NIGALAYE ASHOK G | Director, 10% Owner | J Other deriv | 2015-04-03 | 2015-04-07 | 4,000,000 | — | $0 | 4,000,000 | SEC↗ |
| NIGALAYE ASHOK G | Director, 10% Owner | J Other deriv | 2015-04-03 | 2015-04-07 | 2,684,137 | — | $0 | 2,684,137 | SEC↗ |
| NIGALAYE ASHOK G | Director, 10% Owner | J Other deriv | 2015-04-03 | 2015-04-07 | 6,726,999 | — | $0 | 15,349,042 | SEC↗ |
| NIGALAYE ASHOK G | Director, 10% Owner | J Other deriv | 2015-04-03 | 2015-04-07 | 2,454,665 | — | $0 | 2,454,665 | SEC↗ |
| NIGALAYE ASHOK G | Director, 10% Owner | J Other deriv | 2015-04-03 | 2015-04-07 | 4,000,000 | — | $0 | 0 | SEC↗ |
| NIGALAYE ASHOK G | Director, 10% Owner | J Other deriv | 2015-04-03 | 2015-04-07 | 6,726,999 | — | $0 | 0 | SEC↗ |
| NIGALAYE ASHOK G | Director, 10% Owner | J Other deriv | 2015-04-03 | 2015-04-07 | 2,454,665 | — | $0 | 0 | SEC↗ |
| Hakim Nasrat A | President & CEO | J Other deriv | 2015-04-03 | 2015-04-08 | 1,982,106 | — | $0 | 1,982,106 | SEC↗ |
| Hakim Nasrat A | President & CEO | A Award | 2015-03-05 | 2015-03-09 | 2,046,554 | $0.34 | $695.8K | 13,760,695 | SEC↗ |
| Ward Carter Julian | CFO, Secretary, Treasurer | A Award | 2015-03-05 | 2015-03-09 | 87,711 | $0.34 | $29.8K | 963,293 | SEC↗ |
| TREPPEL JERRY | Chairman of Board | A Award | 2015-03-05 | 2015-03-09 | 87,711 | $0.34 | $29.8K | 9,354,269 | SEC↗ |
| Dash Barry H | Director | A Award | 2015-03-05 | 2015-03-09 | 58,475 | $0.34 | $19.9K | 1,084,229 | SEC↗ |
| WHITNELL JEFFREY A | Director | A Award | 2015-03-05 | 2015-03-09 | 58,475 | $0.34 | $19.9K | 1,035,874 | SEC↗ |
| NARINE JEENARINE | Director, 10% Owner | A Award | 2015-03-05 | 2015-03-09 | 58,475 | $0.34 | $19.9K | 5,568,930 | SEC↗ |
| NIGALAYE ASHOK G | Director, 10% Owner | A Award | 2015-03-05 | 2015-03-09 | 58,475 | $0.34 | $19.9K | 17,167,097 | SEC↗ |
| NIGALAYE ASHOK G | Director, 10% Owner | C Conversion deriv | 2015-01-06 | 2015-05-13 | 1,500,000 | $0.06 | $90.0K | 2,924,333 | SEC↗ |
| NIGALAYE ASHOK G | Chief Scientific Officer | C Conversion deriv | 2015-01-06 | 2015-01-08 | 1,333,333 | $0.06 | $80.0K | 0 | SEC↗ |
| NIGALAYE ASHOK G | Chief Scientific Officer | C Conversion deriv | 2015-01-06 | 2015-01-08 | 1,500,000 | $0.06 | $90.0K | 8,622,043 | SEC↗ |
| NIGALAYE ASHOK G | Chief Scientific Officer | C Conversion | 2015-01-06 | 2015-01-08 | 2,833,333 | $0.06 | $170.0K | 17,108,622 | SEC↗ |
| EPIC INVESTMENTS, LLC | 10% Owner | J Other deriv | 2014-10-17 | 2014-10-21 | 20,000,002 | — | $0 | 6,726,999 | SEC↗ |
| EPIC PHARMA LLC | 10% Owner | J Other deriv | 2014-10-17 | 2014-10-21 | 20,000,002 | — | $0 | 6,726,999 | SEC↗ |
| NIGALAYE ASHOK G | Chief Scientific Officer | J Other deriv | 2014-10-17 | 2014-10-21 | 5,697,710 | — | $0 | 10,122,043 | SEC↗ |
| NIGALAYE ASHOK G | Chief Scientific Officer | J Other deriv | 2014-10-17 | 2014-10-21 | 20,000,002 | — | $0 | 6,726,999 | SEC↗ |
| NARINE JEENARINE | Director, 10% Owner | J Other deriv | 2014-10-17 | 2014-10-21 | 4,178,320 | — | $0 | 8,602,653 | SEC↗ |
| NARINE JEENARINE | Director, 10% Owner | J Other deriv | 2014-10-17 | 2014-10-21 | 20,000,002 | — | $0 | 6,726,999 | SEC↗ |
| Hakim Nasrat A | CEO & President | J Other deriv | 2014-10-17 | 2014-10-21 | 759,695 | — | $0 | 759,695 | SEC↗ |
| Hakim Nasrat A | CEO & President | P Buy | 2014-09-26 | 2014-09-29 | 265,500 | $0.31 | $82.3K | 2,700,000 | SEC↗ |
| Hakim Nasrat A | CEO & President | P Buy | 2014-09-25 | 2014-09-29 | 434,500 | $0.31 | $134.7K | 2,434,500 | SEC↗ |
| TREPPEL JERRY | Chairman of the Board | C Conversion deriv | 2014-09-10 | 2014-09-12 | 4 | $100000.00 | $424.0K | 0 | SEC↗ |
| TREPPEL JERRY | Chairman of the Board | C Conversion | 2014-09-10 | 2014-09-12 | 6,060,000 | — | $0 | 9,266,558 | SEC↗ |
| NARINE JEENARINE | Director, 10% Owner | G Gift deriv | 2014-08-08 | 2014-08-12 | 2,000,000 | — | $0 | 2,757,666 | SEC↗ |
| TREPPEL JERRY | Chairman of the Board | C Conversion deriv | 2014-06-17 | 2014-06-18 | 375,000 | $0.25 | $93.8K | 0 | SEC↗ |
| TREPPEL JERRY | Chairman of the Board | C Conversion deriv | 2014-06-17 | 2014-06-23 | 375,000 | $0.13 | $48.8K | 0 | SEC↗ |
| TREPPEL JERRY | Chairman of the Board | C Conversion | 2014-06-17 | 2014-06-18 | 375,000 | $0.25 | $93.8K | 3,206,558 | SEC↗ |
| TREPPEL JERRY | Chairman of the Board | C Conversion | 2014-06-17 | 2014-06-23 | 375,000 | $0.13 | $48.8K | 3,206,558 | SEC↗ |
| NARINE JEENARINE | Director, 10% Owner | S Sale | 2014-05-09 | 2014-05-13 | 329,437 | $0.38 | $125.2K | 5,510,455 | SEC↗ |
| Dash Barry H | Director | C Conversion deriv | 2014-04-23 | 2014-06-23 | 12,423 | $0.25 | $3.1K | 0 | SEC↗ |
| Dash Barry H | Director | C Conversion | 2014-04-23 | 2014-06-23 | 12,423 | $0.25 | $3.1K | 1,025,754 | SEC↗ |
| NARINE JEENARINE | Director | S Sale | 2014-04-02 | 2015-05-13 | 147,667 | $0.41 | $60.5K | 5,682,877 | SEC↗ |
| NARINE JEENARINE | Director, 10% Owner | S Sale | 2014-04-02 | 2014-04-04 | 147,664 | $0.41 | $60.5K | 5,839,892 | SEC↗ |
| NARINE JEENARINE | Director | S Sale | 2014-04-01 | 2015-05-13 | 157,012 | $0.41 | $64.4K | 5,830,544 | SEC↗ |
| NARINE JEENARINE | Director, 10% Owner | S Sale | 2014-03-27 | 2014-03-31 | 190,172 | $0.43 | $81.8K | 5,987,556 | SEC↗ |
| TREPPEL JERRY | Chairman of the Board | M Exercise deriv | 2014-03-12 | 2014-03-18 | 180,000 | — | $0 | 0 | SEC↗ |
| TREPPEL JERRY | Chairman of the Board | M Exercise | 2014-03-12 | 2014-03-18 | 180,000 | $0.06 | $10.8K | 2,831,558 | SEC↗ |
| EPIC INVESTMENTS, LLC | 10% Owner | S Sale | 2014-03-11 | 2014-03-17 | 239,367 | $0.60 | $143.6K | 67,669,232 | SEC↗ |
| EPIC PHARMA LLC | 10% Owner | S Sale | 2014-03-11 | 2014-03-17 | 239,367 | $0.60 | $143.6K | 67,669,232 | SEC↗ |
| NIGALAYE ASHOK G | Chief Scientific Officer | S Sale | 2014-03-11 | 2014-03-17 | 239,367 | $0.60 | $143.6K | 20,300,770 | SEC↗ |
| NARINE JEENARINE | Director, 10% Owner | S Sale | 2014-03-11 | 2014-03-17 | 239,367 | $0.60 | $143.6K | 14,887,229 | SEC↗ |
| EPIC INVESTMENTS, LLC | 10% Owner | S Sale | 2014-03-07 | 2014-03-10 | 1,051,450 | $0.68 | $715.0K | 67,908,599 | SEC↗ |
| EPIC PHARMA LLC | 10% Owner | S Sale | 2014-03-07 | 2014-03-10 | 1,051,450 | $0.68 | $715.0K | 67,908,599 | SEC↗ |
| NIGALAYE ASHOK G | Chief Scientific Officer | S Sale | 2014-03-07 | 2014-03-10 | 1,051,450 | $0.68 | $715.0K | 20,372,580 | SEC↗ |
| NARINE JEENARINE | Director, 10% Owner | S Sale | 2014-03-07 | 2014-03-10 | 1,051,450 | $0.68 | $715.0K | 14,939,890 | SEC↗ |
| EPIC INVESTMENTS, LLC | 10% Owner | S Sale | 2014-03-06 | 2014-03-10 | 773,050 | $0.90 | $695.7K | 68,960,049 | SEC↗ |
| EPIC PHARMA LLC | 10% Owner | S Sale | 2014-03-06 | 2014-03-10 | 773,050 | $0.90 | $695.7K | 68,960,049 | SEC↗ |
| NIGALAYE ASHOK G | Chief Scientific Officer | S Sale | 2014-03-06 | 2014-03-10 | 773,050 | $0.90 | $695.7K | 20,688,015 | SEC↗ |
| NARINE JEENARINE | Director, 10% Owner | S Sale | 2014-03-06 | 2014-03-10 | 773,050 | $0.90 | $695.7K | 15,171,209 | SEC↗ |
| NIGALAYE ASHOK G | Chief Scientific Officer | C Conversion deriv | 2014-02-25 | 2014-02-27 | 2,000,000 | $0.06 | $120.0K | 1,333,333 | SEC↗ |
| WHITNELL JEFFREY A | Director | A Award | 2014-02-25 | 2014-02-27 | 220,106 | $0.09 | $19.8K | 977,399 | SEC↗ |
| NIGALAYE ASHOK G | Chief Scientific Officer | A Award | 2014-02-25 | 2014-02-27 | 220,106 | $0.09 | $19.8K | 12,275,289 | SEC↗ |
| NIGALAYE ASHOK G | Chief Scientific Officer | C Conversion | 2014-02-25 | 2014-02-27 | 2,000,000 | $0.06 | $120.0K | 14,275,289 | SEC↗ |
| Ward Carter Julian | CFO, Secretary, Treasurer | A Award | 2014-02-25 | 2014-02-27 | 330,159 | $0.09 | $29.7K | 875,582 | SEC↗ |
| Hakim Nasrat A | President & CEO | A Award | 2014-02-25 | 2014-02-27 | 2,616,580 | $0.11 | $287.8K | 11,714,141 | SEC↗ |
| NARINE JEENARINE | Director, 10% Owner | A Award | 2014-02-25 | 2014-02-27 | 220,106 | $0.09 | $19.8K | 6,177,728 | SEC↗ |
| TREPPEL JERRY | Chairman of the Board | A Award | 2014-02-25 | 2014-03-03 | 330,159 | $0.09 | $29.7K | 2,760,006 | SEC↗ |
| Dash Barry H | Director | A Award | 2014-02-25 | 2014-03-03 | 220,106 | $0.09 | $19.8K | 1,013,331 | SEC↗ |
| Hakim Nasrat A | President & CEO | C Conversion deriv | 2014-02-07 | 2014-02-11 | 10,000,000 | $100000.00 | $1000.00B | 0 | SEC↗ |
| TREPPEL JERRY | Chairman of the Board | C Conversion deriv | 2014-02-07 | 2014-02-11 | 600,000 | $141442.72 | $84.87B | 0 | SEC↗ |
| Hakim Nasrat A | President & CEO | C Conversion | 2014-02-07 | 2014-02-11 | 100 | $100000.00 | $10.00M | 100 | SEC↗ |
| TREPPEL JERRY | Chairman of the Board | C Conversion | 2014-02-07 | 2014-02-11 | 4 | $141442.72 | $599.7K | 4 | SEC↗ |
| EPIC INVESTMENTS, LLC | 10% Owner | S Sale | 2014-01-13 | 2014-01-17 | 805,538 | $0.18 | $145.0K | 69,733,099 | SEC↗ |
| EPIC PHARMA LLC | 10% Owner | S Sale | 2014-01-13 | 2014-01-17 | 805,583 | $0.18 | $145.0K | 69,733,099 | SEC↗ |
| NIGALAYE ASHOK G | Chief Scientific Officer | S Sale | 2014-01-13 | 2014-01-17 | 805,583 | $0.18 | $145.0K | 20,919,930 | SEC↗ |
| NARINE JEENARINE | Director, 10% Owner | S Sale | 2014-01-13 | 2014-01-17 | 805,583 | $0.18 | $145.0K | 15,341,280 | SEC↗ |
| EPIC PHARMA LLC | 10% Owner | S Sale | 2013-12-05 | 2013-12-13 | 275,000 | $0.13 | $35.8K | 71,004,867 | SEC↗ |
| NIGALAYE ASHOK G | Chief Scientific Officer | S Sale | 2013-12-05 | 2013-12-13 | 275,000 | $0.13 | $35.8K | 21,301,460 | SEC↗ |
| NARINE JEENARINE | Director, 10% Owner | S Sale | 2013-12-05 | 2013-12-13 | 275,000 | $0.13 | $35.8K | 15,621,069 | SEC↗ |
| EPIC INVESTMENTS, LLC | 10% Owner | S Sale | 2013-12-05 | 2013-12-16 | 275,000 | $0.13 | $35.8K | 71,004,867 | SEC↗ |
| EPIC INVESTMENTS, LLC | 10% Owner | S Sale | 2013-12-02 | 2013-12-04 | 100,000 | $0.13 | $13.0K | 71,303,493 | SEC↗ |
| EPIC PHARMA LLC | 10% Owner | S Sale | 2013-12-02 | 2013-12-04 | 100,000 | $0.13 | $13.0K | 71,303,493 | SEC↗ |
| NIGALAYE ASHOK G | Chief Scientific Officer | S Sale | 2013-12-02 | 2013-12-04 | 100,000 | $0.13 | $13.0K | 21,391,048 | SEC↗ |
| NARINE JEENARINE | Director, 10% Owner | D To issuer | 2013-12-02 | 2013-12-04 | 100,000 | $0.13 | $13.0K | 15,686,768 | SEC↗ |
| EPIC INVESTMENTS, LLC | 10% Owner | S Sale | 2013-11-27 | 2013-11-29 | 25,000 | $0.12 | $3.0K | 71,403,493 | SEC↗ |
| EPIC PHARMA LLC | 10% Owner | S Sale | 2013-11-27 | 2013-11-29 | 25,000 | $0.12 | $3.0K | 71,403,493 | SEC↗ |
| NIGALAYE ASHOK G | Chief Scientific Officer | S Sale | 2013-11-27 | 2013-11-29 | 25,000 | $0.12 | $3.0K | 21,421,048 | SEC↗ |
| NARINE JEENARINE | Director, 10% Owner | S Sale | 2013-11-27 | 2013-11-29 | 25,000 | $0.12 | $3.0K | 15,708,769 | SEC↗ |
| EPIC INVESTMENTS, LLC | 10% Owner | S Sale | 2013-11-26 | 2013-11-29 | 357,000 | $0.12 | $42.8K | 71,428,493 | SEC↗ |
| EPIC PHARMA LLC | 10% Owner | S Sale | 2013-11-26 | 2013-11-29 | 357,000 | $0.12 | $42.8K | 71,428,493 | SEC↗ |
| NIGALAYE ASHOK G | Chief Scientific Officer | S Sale | 2013-11-26 | 2013-11-29 | 357,000 | $0.12 | $42.8K | 21,428,528 | SEC↗ |
| NARINE JEENARINE | Director, 10% Owner | S Sale | 2013-11-26 | 2013-11-29 | 357,000 | $0.12 | $42.8K | 15,714,268 | SEC↗ |
| EPIC PHARMA LLC | 10% Owner | S Sale | 2013-11-26 | 2013-12-13 | 23,626 | $0.12 | $2.8K | 71,279,867 | SEC↗ |
| NIGALAYE ASHOK G | Chief Scientific Officer | S Sale | 2013-11-26 | 2013-12-13 | 23,626 | $0.12 | $2.8K | 21,383,960 | SEC↗ |
| NARINE JEENARINE | Director, 10% Owner | S Sale | 2013-11-26 | 2013-12-13 | 23,626 | $0.12 | $2.8K | 15,681,569 | SEC↗ |
| EPIC INVESTMENTS, LLC | 10% Owner | S Sale | 2013-11-26 | 2013-12-16 | 23,626 | $0.12 | $2.8K | 71,279,867 | SEC↗ |
| EPIC INVESTMENTS, LLC | 10% Owner | S Sale | 2013-11-19 | 2013-11-19 | 21,000 | $0.12 | $2.5K | 71,824,493 | SEC↗ |
| EPIC PHARMA LLC | 10% Owner | S Sale | 2013-11-19 | 2013-11-19 | 21,000 | $0.12 | $2.5K | 71,824,493 | SEC↗ |
| NIGALAYE ASHOK G | Chief Scientific Officer | S Sale | 2013-11-19 | 2013-11-19 | 21,000 | $0.12 | $2.5K | 21,547,348 | SEC↗ |
| NARINE JEENARINE | Director, 10% Owner | S Sale | 2013-11-19 | 2013-11-19 | 21,000 | $0.12 | $2.5K | 15,801,388 | SEC↗ |
| EPIC INVESTMENTS, LLC | 10% Owner | S Sale | 2013-11-18 | 2013-11-19 | 1,170,000 | $0.12 | $140.4K | 71,845,493 | SEC↗ |
| EPIC PHARMA LLC | 10% Owner | S Sale | 2013-11-18 | 2013-11-19 | 1,170,000 | $0.12 | $140.4K | 71,845,493 | SEC↗ |
| NIGALAYE ASHOK G | Chief Scientific Officer | S Sale | 2013-11-18 | 2013-11-19 | 1,170,000 | $0.12 | $140.4K | 21,553,648 | SEC↗ |
| NARINE JEENARINE | Director, 10% Owner | S Sale | 2013-11-18 | 2013-11-19 | 1,170,000 | $0.12 | $140.4K | 15,806,008 | SEC↗ |
| EPIC INVESTMENTS, LLC | 10% Owner | S Sale | 2013-11-15 | 2014-01-06 | 253,050 | $0.12 | $30.4K | 72,950,493 | SEC↗ |
| EPIC PHARMA LLC | 10% Owner | S Sale | 2013-11-15 | 2014-01-06 | 253,050 | $0.12 | $30.4K | 72,950,493 | SEC↗ |
| NIGALAYE ASHOK G | Chief Scientific Officer | S Sale | 2013-11-15 | 2014-01-06 | 253,050 | $0.12 | $30.4K | 21,885,148 | SEC↗ |
| NARINE JEENARINE | Director, 10% Owner | S Sale | 2013-11-15 | 2014-01-06 | 253,050 | $0.12 | $30.4K | 16,049,109 | SEC↗ |
| EPIC INVESTMENTS, LLC | 10% Owner | S Sale | 2013-11-15 | 2014-01-06 | 253,050 | $0.12 | $30.4K | 72,950,493 | SEC↗ |
| EPIC PHARMA LLC | 10% Owner | S Sale | 2013-11-15 | 2014-01-06 | 253,050 | $0.12 | $30.4K | 72,950,493 | SEC↗ |
| EPIC INVESTMENTS, LLC | 10% Owner | S Sale | 2013-11-15 | 2013-11-19 | 318,050 | $0.12 | $38.2K | 73,015,493 | SEC↗ |
| EPIC PHARMA LLC | 10% Owner | S Sale | 2013-11-15 | 2013-11-19 | 318,050 | $0.12 | $38.2K | 73,015,493 | SEC↗ |
| NIGALAYE ASHOK G | Chief Scientific Officer | S Sale | 2013-11-15 | 2013-11-19 | 318,050 | $0.12 | $38.2K | 24,095,113 | SEC↗ |
| NARINE JEENARINE | Director, 10% Owner | S Sale | 2013-11-15 | 2013-11-19 | 318,050 | $0.12 | $38.2K | 16,063,408 | SEC↗ |
| EPIC INVESTMENTS, LLC | 10% Owner | S Sale | 2013-11-14 | 2013-11-19 | 465,090 | $0.12 | $55.8K | 73,333,543 | SEC↗ |
| EPIC PHARMA LLC | 10% Owner | S Sale | 2013-11-14 | 2013-11-19 | 465,090 | $0.12 | $55.8K | 73,333,543 | SEC↗ |
| NIGALAYE ASHOK G | Chief Scientific Officer | S Sale | 2013-11-14 | 2013-11-19 | 465,090 | $0.12 | $55.8K | 24,200,069 | SEC↗ |
| NARINE JEENARINE | Director, 10% Owner | S Sale | 2013-11-14 | 2013-11-19 | 465,090 | $0.12 | $55.8K | 16,133,379 | SEC↗ |
| EPIC INVESTMENTS, LLC | 10% Owner | S Sale | 2013-11-11 | 2013-11-29 | 39,000 | $0.12 | $4.7K | 71,785,493 | SEC↗ |
| EPIC PHARMA LLC | 10% Owner | S Sale | 2013-11-11 | 2013-11-29 | 39,000 | $0.12 | $4.7K | 71,785,493 | SEC↗ |
| NIGALAYE ASHOK G | Chief Scientific Officer | S Sale | 2013-11-11 | 2013-11-29 | 39,000 | $0.12 | $4.7K | 21,535,048 | SEC↗ |
| NARINE JEENARINE | Director, 10% Owner | S Sale | 2013-11-11 | 2013-11-29 | 39,000 | $0.12 | $4.7K | 15,792,808 | SEC↗ |
| EPIC INVESTMENTS, LLC | 10% Owner | S Sale | 2013-11-06 | 2013-11-08 | 122,200 | $0.12 | $14.7K | 73,798,633 | SEC↗ |
| EPIC PHARMA LLC | 10% Owner | S Sale | 2013-11-06 | 2013-11-08 | 122,200 | $0.12 | $14.7K | 73,798,633 | SEC↗ |
| NIGALAYE ASHOK G | Chief Scientific Officer | S Sale | 2013-11-06 | 2013-11-08 | 122,200 | $0.12 | $14.7K | 22,139,590 | SEC↗ |
| NARINE JEENARINE | Director, 10% Owner | S Sale | 2013-11-06 | 2013-11-08 | 122,200 | $0.12 | $14.7K | 16,235,699 | SEC↗ |
| EPIC INVESTMENTS, LLC | 10% Owner | S Sale | 2013-10-29 | 2013-10-30 | 466,000 | $0.13 | $60.6K | 73,920,833 | SEC↗ |
| EPIC PHARMA LLC | 10% Owner | S Sale | 2013-10-29 | 2013-10-30 | 466,000 | $0.13 | $60.6K | 73,920,833 | SEC↗ |
| NIGALAYE ASHOK G | Chief Scientific Officer | S Sale | 2013-10-29 | 2013-10-30 | 139,800 | $0.13 | $18.2K | 22,176,250 | SEC↗ |
| NARINE JEENARINE | Director, 10% Owner | S Sale | 2013-10-29 | 2013-10-30 | 102,520 | $0.01 | $1.0K | 16,262,583 | SEC↗ |
| EPIC INVESTMENTS, LLC | 10% Owner | S Sale | 2013-10-28 | 2013-10-30 | 465,000 | $0.13 | $60.5K | 74,386,833 | SEC↗ |
| EPIC PHARMA LLC | 10% Owner | S Sale | 2013-10-28 | 2013-10-30 | 465,000 | $0.13 | $60.5K | 74,386,833 | SEC↗ |
| NIGALAYE ASHOK G | Chief Scientific Officer | S Sale | 2013-10-28 | 2013-10-30 | 139,500 | $0.13 | $18.1K | 22,316,050 | SEC↗ |
| NARINE JEENARINE | Director, 10% Owner | S Sale | 2013-10-28 | 2013-10-30 | 102,300 | $0.13 | $13.3K | 16,365,103 | SEC↗ |
| EPIC INVESTMENTS, LLC | 10% Owner | C Conversion deriv | 2013-09-10 | 2013-09-18 | 1,600 | — | $0 | 0 | SEC↗ |
| EPIC PHARMA LLC | 10% Owner | C Conversion deriv | 2013-09-10 | 2013-09-18 | 1,600 | — | $0 | 0 | SEC↗ |
| NIGALAYE ASHOK G | Scief Scientific Officer | C Conversion deriv | 2013-09-10 | 2013-09-18 | 1,600 | — | $0 | 0 | SEC↗ |
| NARINE JEENARINE | Director | C Conversion deriv | 2013-09-10 | 2013-09-18 | 1,600 | — | $0 | 0 | SEC↗ |
| EPIC INVESTMENTS, LLC | 10% Owner | C Conversion | 2013-09-10 | 2013-09-18 | 65,843,621 | $0.02 | $1.32M | 74,851,833 | SEC↗ |
| EPIC PHARMA LLC | 10% Owner | C Conversion | 2013-09-10 | 2013-09-18 | 65,843,621 | $0.02 | $1.32M | 74,851,833 | SEC↗ |
| NIGALAYE ASHOK G | Scief Scientific Officer | C Conversion | 2013-09-10 | 2013-09-18 | 19,753,086 | $0.02 | $395.1K | 22,455,550 | SEC↗ |
| NARINE JEENARINE | Director | C Conversion | 2013-09-10 | 2013-09-18 | 14,485,597 | $0.02 | $289.7K | 16,467,403 | SEC↗ |
| Plassche Douglas | Senior VP of Operations | A Award deriv | 2013-07-23 | 2015-06-22 | 3,000,000 | — | $0 | 3,000,000 | SEC↗ |
| EPIC INVESTMENTS, LLC | 10% Owner | D To issuer | 2013-05-09 | 2013-05-13 | 391,500 | $0.07 | $27.4K | 9,008,212 | SEC↗ |
| EPIC PHARMA LLC | 10% Owner | D To issuer | 2013-05-09 | 2013-05-13 | 391,500 | $0.07 | $27.4K | 9,008,212 | SEC↗ |
| POTTI RAM | 10% Owner | D To issuer | 2013-05-09 | 2013-05-13 | 391,500 | $0.07 | $27.4K | 15,235,392 | SEC↗ |
| NARINE JEENARINE | Director, 10% Owner | D To issuer | 2013-05-09 | 2013-05-13 | 391,500 | $0.07 | $27.4K | 14,965,834 | SEC↗ |
| NIGALAYE ASHOK G | Chief Scientific Officer | D To issuer | 2013-05-09 | 2013-05-13 | 391,500 | $0.07 | $27.4K | 21,063,395 | SEC↗ |
| EPIC INVESTMENTS, LLC | 10% Owner | D To issuer | 2013-04-29 | 2015-04-27 | 140,000 | $0.08 | $11.2K | 9,399,712 | SEC↗ |
| EPIC PHARMA LLC | 10% Owner | D To issuer | 2013-04-29 | 2015-04-27 | 140,000 | $0.08 | $11.2K | 9,399,712 | SEC↗ |
| POTTI RAM | Director, 10% Owner | D To issuer | 2013-04-29 | 2015-04-27 | 140,000 | $0.08 | $11.2K | 24,538,536 | SEC↗ |
| NARINE JEENARINE | Director, 10% Owner | D To issuer | 2013-04-29 | 2015-04-27 | 140,000 | $0.08 | $11.2K | 24,268,978 | SEC↗ |
| NIGALAYE ASHOK G | Chief Scientific Officer | D To issuer | 2013-04-29 | 2015-04-27 | 140,000 | $0.08 | $11.2K | 30,366,536 | SEC↗ |
| EPIC INVESTMENTS, LLC | 10% Owner | D To issuer | 2013-04-29 | 2013-04-29 | 130,000 | $0.08 | $10.4K | 9,399,712 | SEC↗ |
| EPIC INVESTMENTS, LLC | 10% Owner | J Other | 2013-04-29 | 2013-04-29 | 13,367,481 | $0.04 | $534.7K | 9,529,712 | SEC↗ |
| EPIC PHARMA LLC | 10% Owner | D To issuer | 2013-04-29 | 2013-04-29 | 130,000 | $0.08 | $10.4K | 9,399,712 | SEC↗ |
| EPIC PHARMA LLC | 10% Owner | J Other | 2013-04-29 | 2013-04-29 | 13,367,481 | $0.04 | $534.7K | 9,529,712 | SEC↗ |
| NIGALAYE ASHOK G | Chief Scientific Officer | D To issuer | 2013-04-29 | 2013-04-29 | 130,000 | $0.08 | $10.4K | 30,366,546 | SEC↗ |
| NIGALAYE ASHOK G | Chief Scientific Officer | J Other | 2013-04-29 | 2013-04-29 | 13,367,481 | $0.04 | $534.7K | 16,999,068 | SEC↗ |
| NARINE JEENARINE | Director, 10% Owner | D To issuer | 2013-04-29 | 2013-04-30 | 130,000 | $0.08 | $10.4K | 24,268,988 | SEC↗ |
| NARINE JEENARINE | Director, 10% Owner | J Other | 2013-04-29 | 2013-04-30 | 13,367,481 | $0.04 | $534.7K | 15,357,334 | SEC↗ |
| POTTI RAM | 10% Owner | D To issuer | 2013-04-29 | 2013-04-30 | 130,000 | $0.08 | $10.4K | 24,538,546 | SEC↗ |
| POTTI RAM | 10% Owner | J Other | 2013-04-29 | 2013-04-30 | 13,367,481 | $0.04 | $534.7K | 15,626,892 | SEC↗ |
| EPIC INVESTMENTS, LLC | 10% Owner | J Other deriv | 2013-04-26 | 2013-04-29 | 13,272,999 | — | $0 | 26,727,001 | SEC↗ |
| EPIC INVESTMENTS, LLC | 10% Owner | C Conversion deriv | 2013-04-26 | 2013-04-29 | 200 | $1000.00 | $200.0K | 1,600 | SEC↗ |
| EPIC PHARMA LLC | 10% Owner | J Other deriv | 2013-04-26 | 2013-04-29 | 13,272,999 | — | $0 | 26,727,001 | SEC↗ |
| EPIC PHARMA LLC | 10% Owner | C Conversion deriv | 2013-04-26 | 2013-04-29 | 200 | $1000.00 | $200.0K | 1,600 | SEC↗ |
| NIGALAYE ASHOK G | Chief Scientific Officer | C Conversion deriv | 2013-04-26 | 2013-04-29 | 200 | $1000.00 | $200.0K | 1,600 | SEC↗ |
| NIGALAYE ASHOK G | Chief Scientific Officer | J Other deriv | 2013-04-26 | 2013-04-29 | 13,272,999 | — | $0 | 26,727,001 | SEC↗ |
| NARINE JEENARINE | Director, 10% Owner | C Conversion deriv | 2013-04-26 | 2013-04-30 | 200 | $1000.00 | $200.0K | 1,600 | SEC↗ |
| NARINE JEENARINE | Director, 10% Owner | J Other deriv | 2013-04-26 | 2013-04-30 | 13,272,999 | — | $0 | 26,727,001 | SEC↗ |
| POTTI RAM | 10% Owner | C Conversion deriv | 2013-04-26 | 2013-04-30 | 200 | $1000.00 | $200.0K | 1,600 | SEC↗ |
| NIGALAYE ASHOK G | Chief Scientific Officer | J Other deriv | 2013-04-26 | 2013-04-30 | 4,424,333 | — | $0 | 26,727,001 | SEC↗ |
| NARINE JEENARINE | Director, 10% Owner | J Other deriv | 2013-04-26 | 2013-04-30 | 4,424,333 | — | $0 | 26,727,001 | SEC↗ |
| POTTI RAM | 10% Owner | J Other deriv | 2013-04-26 | 2013-04-30 | 4,424,333 | — | $0 | 26,727,001 | SEC↗ |
| EPIC INVESTMENTS, LLC | 10% Owner | C Conversion | 2013-04-26 | 2013-04-29 | 8,230,453 | — | $0 | 22,897,193 | SEC↗ |
| EPIC INVESTMENTS, LLC | 10% Owner | D To issuer | 2013-04-26 | 2013-04-29 | 243,926 | $0.08 | $19.5K | 14,666,740 | SEC↗ |